# Open Label Study of TRx0014 in Alzheimer's Disease

> **NCT00684944** · PHASE2 · COMPLETED · sponsor: **TauRx Therapeutics Ltd** · enrollment: 111 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** TRx0014

## Key facts

- **NCT ID:** NCT00684944
- **Lead sponsor:** TauRx Therapeutics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09-13
- **Primary completion:** 2010-12-02
- **Final completion:** 2010-12-02
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2018-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684944, "Open Label Study of TRx0014 in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00684944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*